Industry: Medical equipment Region: Sweden Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
The company is a start-up enterprise located in Helsingborg, Sweden, but its hand-held non-invasive intracardiac pressure monitoring equipment has attracted wide attention in the industry.
At present, the accurate method to monitor the early symptoms of heart failure is to insert a right heart catheter or insert an intracardiac pressure monitor in the patient's lung. Although right heart catheterization is a common and low-risk operation, it is expensive, resource-intensive and usually very uncomfortable for patients with already fragile heart failure. Invasive pressure monitors are very expensive, which limits their applicability in the market.
The company developed a hand-held medical device for noninvasive monitoring of intracardiac pressure to help improve nursing, reduce hospitalization due to heart failure and reduce mortality. Clinically, the accuracy of heart monitor can be comparable to the current invasive standards in the market.
It takes only a few minutes to measure with this monitoring equipment, and no professional team, special room or other equipment is needed. The device only needs to be fixed on the patient's chest, and at the same time, data is collected by five different sensors and analyzed by machine learning. The resulting intracardiac pressure is then displayed to the doctor through the screen of the device. This product can measure the intracardiac pressure in a non-invasive way, but at present, it can only be measured by invasive surgery (such as surgery). This product can help reduce the mortality rate of patients with heart failure, significantly reduce the cost and readmission rate, and provide a better experience for the affected patients.
The company has received positive comments from cardiologists, health care professionals and health care economists, and has been in continuous dialogue with clinics, hospitals, integrated delivery networks (IDN), provider networks (PN) and insurance providers to bring products to market. The company has been nominated for many competitions and has established long-term partnerships with leading hospitals in Sweden, Europe and the United States.
The team of this company is composed of people with deep knowledge in their respective fields. The management team has many years of knowledge in medical care, intellectual property, hardware, machine learning, software, commercialization and marketing. The company is also composed of professionals in clinical operation, management strategy, product development and finance.
Cooperation mode:
At present, the company is looking for investors, raising funds of 1.6 million euros.